FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes
de Poel, E., Spelier, S., Hagemeijer, M.C., van Mourik, P., Suen, S.W.F., Vonk, A.M., Brunsveld, J.E., Ithakisiou, G.N., Kruisselbrink, E., Oppelaar, H., Berkers, G., de Winter de Groot, K.M., Heida-Michel, S., Jans, S.R., van Panhuis, H., Bakker, M., van der Meer, R., Roukema, J., Dompeling, E., Weersink, E.J.M., Koppelman, G.H., Blaazer, A.R., Muijlwijk-Koezen, J.E., van der Ent, C.K., Beekman, J.M.
Published in Journal of cystic fibrosis (01.05.2023)
Published in Journal of cystic fibrosis (01.05.2023)
Get full text
Journal Article
Career development in fragment-based drug discovery
Romasanta, A.K.S., van der Sijde, P.C., Smit, M.J., de Esch, I.J.P., Jahnke, W., van Muijlwijk-Koezen, J.E.
Published in Drug discovery today. Technologies (01.12.2020)
Published in Drug discovery today. Technologies (01.12.2020)
Get full text
Journal Article